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Inhibition of DNA and Protein Synthesis in UV -Irradiated Mouse Skin by 
2-Difluoromethylornithine, Methylglyoxal bis(Guanylhydrazone), and 
Their Combination 
KIRST! KA.PYAHO, PH.D ., JORMA LAUHARANTA, M .D. , AND JUHAN! JA.NNE, M.D. 
Department of Biochemist1y, University of Helsinlli, and Department of Dermatology, University Central Hospital, Helsinhi, Finland 
Exposure of mouse skin to UVB irradiation greatly 
enhanced the biosynth esis and accumulation of putres-
cine and sp ermidine before or concomitantly with stim-
ulation of epidermal m acromolecular (DNA and protein) 
synthesis. Topical treatment of UV-exposed skin with 2 
inhibitors of polyamine biosynthesis , 2-difluorometh-
ylornithine (DFMO) and m ethylglyoxal bis(guanyl-
hydrazone) (MGBG) prevented the enhanced epidermal 
accumulation of polyamines, especially spermidine, and 
also inhibited the incorporation of radioactive precur-
sors into DNA and protein. When applied in combination, 
these 2 antimetabolites of polyamines produced an in-
hibition of macromolecuiar synthesis that was at least 
additive: [!H]thymidine incorporation decreased b y 80% 
and r4 C]leucine incorporation by 44% as compared with 
the UVB-irradiated control mice. A slight decrease in 
the ratio of flH]histidine/[14C]leucine incorporation in-
dicated that protein synthesis of the differentiating cell 
layers was also affected by the inhibitors. The effects of 
the combined DFMO and MGBG treatment were paor-
tially reversed by concomitant topical application of 
spermidine. 
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Interest in polyamine m etabolism a mong d ermatologists 
arose in mid 1970s, when Proctor et al [1] first r eported t hat 
blood of psoriatic patients con tains high concentrations of sper-
midine and spermine . S ince then, elevated polyamine levels 
have been reported in psoriatic lesions [2-4] a nd in t he urine of 
psoriatic patients [3]. Moreover , successful treatment of th e 
disease resulted in a d ecline of the polyamine concentrations 
approximately to th e levels found in h ealth y epidermis [4]. 
Enhanced polyamine synth esis was similarly reported in huma n 
cutaneous epitheliomas [5]. 
Presently, experimental data obtained with a nimal m odels 
indicate t h at epidermal prolife ration is invaYiably accompa nied 
by a n enha ncement of polyamine biosynthesis; wound h ealing 
[6], induction of skin tumors by tumor promoters [7-9], and 
UVB irradiation [10-12] all result in a n increased polyamine 
accumulation in the affected epidermis. Further , topical appli-
cation of putrescine or spermine has been reported to s timulate 
DNA synth esis in mouse epidermis [13]. 
The syn th esis of the physiologic polyamines, is regulated 
m a inly by 2 inducible enzymes, ornithine decarboxylase and 
adenosylmethionine decarboxylase. Ornithine decarboxylase 
catalyzes the formation of putrescine from ornithine, while · 
adenosylmethionine decarboxylase produces decarboxylated S -
ade nosylmethionine which is requil'ed for t he synth esis of sper-
midine (from putrescine) and spermine (from spermidine) 
[14]. In mouse skin , DL-hydrazinoa minovaleric acid, a compet-
itive inhibitor of ornithine decarboxylase inhibits th e induction 
of skin proliferation produced by ethylphenylpropiolate [15]. 
Tumor formation in mouse skin is almost totally prevented by 
2-difluoromethylornithine (DFMO) [16], a highly specific and 
practically nontoxic irreversible inhibitor of ornithine decarbox-
ylase [17]. However, Seiler and Knodgen [11] obtained only a 
marginal inhibition of mouse epidermal DNA synthesis by 
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peroral DFMO t reatment. Methylglyoxal bis(guanylhydrazone) 
(MGBG) is a potent competitive inhibitor of adenosylmethion-
ine decarboxylase [18], which at millimolar concentrations also 
produces extensive mitochondrial damage [19,20) and causes 
rapid cell death [21]. In their work with cultured human kera -
tinocytes, Proctor et al [22) showed that micromolar concentra-
tions of MGBG inhibited keratinocyte prolifer ation and pro-
moted their differentiation. The extent of differentiation was 
estimated by using the ratio of histidine/leucine incorporation 
into the cellular protein, which reflects t he rate of th e synthesis 
of histidine-rich keratinous proteins occwTing preferably in th e 
granular layer. 
We have recently shown t hat polyamine depletion produced 
by DFMO treatment greatly increases the uptake of MGBG 
into mouse epidermis [23], a phenomenon previously well doc-
umented not only in cell cultures [24) and experimental animals 
[25] , but also in human leukemia [26). The theoretical basis of 
this stimulation is based on the fact that polyamine-deprived 
cells attempt to normalize abnormally low intracellular polya-
mine pools by enhancing the uptake of extracellular polyamines 
[27r As MGBG is structurally a congener of spermidine, it is 
actively transported into polyamine-deficient cells via the pol-
yamine uptake system [21,28]. 
Since systemic administration of MGBG is likely to produce 
undesirable side effects, we developed a convenient topical 
application system for DFMO and MGBG [29). In the present 
work we will show that a topical treatment of mouse skin with 
DFMO and MGBG, especially in combination, prevents the 
UVB-induced epidermal polyamine accumulation and results 
in a profound inhibition of DNA syn t hesis and, to a lesser 
extent, protein synthesis. Topical spermidine partially reversed 
the inhibitory effects of the combined DFMO a nd M GBG on 
t h e macromolecular synthesis. 
MATERIALS AND METHODS 
Animals and Treatments 
Female albino mice were used in all experiments. After an initial 
haircut with scissors, the dorsal hai1· was removed with the aid of cream 
hail· remover. Only animals showing no hail· regrowth were used. 
The animals treated with DFMO received the dl'ug in dJ'inking water 
(3% solution) for 3 days before the UV irradiation. Aftel' the irradiation 
DFMO was applied topically as a 20% ointment (Ambilan base, Orion, 
Espoo, Finland) twice a day. MGBG and spermidine were applied as 50 
mM ointments also twice a day, stal'ting immediately after the irradia-
tion. When DFMO and MGBG, or DFMO, MGBG, and spermidine 
were given together, all compounds were combined in a single oin tment. 
The topical tJ·eatment was continued for 48 h, thus involving 4 ru·ug 
applications. The skin was washed 2 h before killing, and the prepal'a-
t ron of the epidermal samples was performed as described previously 
[23]. Each experimental group consisted of 5 mice. 
Irradiation of the skin was accomplished with a UVB lamp (;\,"" 310 
nm, Airam, Finland) for 10 min at a distance of 40 em (total dose 0.15 
J/cm). For the determination of rad ioactive incorporation into DNA 
and pl'Otein, 25 f.'Ci of ['1H] thymidine, 2.5 f.'Ci of [ 14C]leucine, and 5.0 
1.1Ci of ['1H]histidine was inj ected i.p. 1 h before killing. 
C h emicals 
Difluoromethylornithine was a generous gift from the Centre de 
Recherche Merrell In ternational (Strasbourg, France). The diacetate 
salt of methylglyoxal bis(guanylhydl'azone) was synthesized by Orion 
P harmaceutical Company (Espoo, Finland). S-Adenosyl-L-[l- 1'1C]me-
thionine was prepared enzymically as described in [30]. [6-"H]Thymi-
dine (specific radioactivity 30 Ci/mmol) , L-["C(U)]leucine (specific 
radioactivity 330 mCi/mmol) , and L-[2,5-3H]histidine (specific radio-
activity 51 Ci/mmol) were purchased fTom Amersham International 
Ltd (Amersham, U.K.). 
Analytical Methods 
The activity of adenosylmethionine decarboxylase was assayed as in 
[31]. Polyammes were determined from perchloric acid extracts by the 
method of Seiler [32] using the solvent system of Dreyfuss et al· [33]. 
MGBG was deternuned enzynucally from neutra lized perchloric acid 
extracts by the method of Seppiinen et al [34] using adenosylmethionine 
decarboxylase Isolated from baker's yeast. DNA was measured by the 
method of Giles and Myers [35], and protein by the method of Lowry 
et al [36]. The incorporation of radioactive thymidine into DNA was 
determined by liquid scintillation counting after hydrolysis of the 
samples in hot 5% trichloroacetic acid. The protein precipitate obtained 
after trichloroacetic acid hyru·olysis was washed, dissolved in 0. 1 N 
NaOH, and counted for radioactivity. 
RESULTS 
UVB irrad iation enhanced DNA and protein synth esis in 
m ouse epidermis. Both synth etic activities reached their max-
imum at 48 h after the irradiation (Fig 1) , and th e epidermal 
protein content was nearly doubled in 4 days (results not 
shown) . As also described earlier by Seiler and Knodgen [ll), 
the epidermal spermidine concentration increased 3-fold by 48 
h , while cha nges in the other polyamines were smaller. Orni-
thine decarboxylase activity reached a peak at 24 h and aden-
osylmethionine decarboxylase was stimulated 2-fold at 48 h 
(results not shown) . 
When the animals received DFMO in drinking water for 3 
days before the irradiation, and in an ointment for 2 days 
thereafter, the increase in epidermal putrescine and spermidine 
concentrations was prevented, whereas spermine concentration 
was somewhat increased (Table 1) . Topical application of 
MGBG decreased both spermidine and spermin e levels and the 
combination of the 2 drugs led to a further decrease of epidermal 
spermidine concentration (Table 1) . The intracellular accumu-
lation of MGBG was reflected by t he remarkable increase of 
the epidermal adenosylmethionine decarboxylase activity 
(Table I) due to the stabilization of th e enzyme molecule by 
MGBG binding [37). 
Both DFMO and MGBG alone h ad a moderate inhibitory 
effect on ~piderm~l DNA synth esis (Table II), but pretreatment 
of the ammals with peroral DFMO, followed by a combined 
topical application of DFMO and MGBG, produced an inhibi-
tory effect not achievable with either drug alone: th e incorpo-
ratiOn of ['1H]thymidine decreased to 20% of the control value 
(Table II) . 
The effect of DFMO a nd MGBG on epidermal protein syn-
thesiS ~as_c?~1parable to that on DNA synth esis, yet the extent 
o~ th~ mhibitJon produced by the drugs was smaller: th e com-
bm~twn_ of DF_MO and MGBG decreased th e incorporation of 
radiOactive ammo acids to about h alf of th e control value (Table 
III). The inhibi t ion of protein syn th esis was also reflected by a 
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TABLE I. Effect of 2-difluoromethyl~rnithine (DFMO), methylglyoxal bis(guanylhydrazone) (MGBG), and spermidine treatments on 
adenosylmethwmne decarboxylase (AMDC) activity and polyamine levels in mouse epidermis 
Treatment" AMDC activity• Putrescine Spermidine (nmol/mg protein/h) (nmol/mg DNA) Spermine 
None 0.7 ± 0.1c 77 ± 15 601 ± 63 168 ± 18 
DFMO 2.4 ± 0.2" 10 ± 0' 308 ± 24c 193 ± 13 
MGBG 32.1 ± 1.7" 33 ± 4{ 326 ± 27' 74 ± 10' 
DFMO + MGBG 34.1 ± 2.6<1 87 ± 34 281 ± 34' 96 ± 6' 
DFMO + MGBG + 24.0 ± 1.8" 112 ± 141 1097 ± 147{ 70 ± 14' 
spermidine 
Spermidine 1.6 + 0.2' 88 + 1 1239 + 275 127 + 18 
" The schedule of the treatments is described in Materials and M ethods. 
"AMDC activity was assayed after dia lysis of the samples to remove all MGBG. 
<Mean± SEM. 
d p < 0.001. 
e P < 0.01. 
r p < 0.05. 
TABLE II. DNA synthesis in mouse epidermis following 2-
. dtfluoromethylornithine (DFMO), methylglyoxal 
bts(guanylhydrazone) (MGBG), and spermidine treatments 
Treatment(/ 
None 
DFMO 
MGBG 
DFMO+ MGBG 
DFMO +MGBG+ 
spermidine 
Spermidine 
["H]Thymidine 
incorporation 
(cpm!J<g DNA) 
120 ± 21" 
71 ± 8 
50± 8'' 
23 ± 6c 
75 ± 12 
194 ± 91 
DNA content 
(JLg/mg tissue) 
2.37 ± 0.10 
2.44 ± 0.11 
2.51 ± 0.18 
2.18 ± 0.07 
2.27 ± 0.04 
2.17 + 0.06 
" The schedule 
Methods . 
of the treatments is described in Materials and 
" Mean± SEM. 
c p < 0.01. 
decrease in totaJ protein content of the epidermaJ tissue (Table 
III) . 
Earlier studies by Fukuyama and Epstein [38,39] have shown 
that the incorporation of radioactive amino acids into different 
epidermaJ layers is not uniform, but some amino acids, e.g., 
leucine, preferably incorporate into basal cells, while others, 
suc4 as histidine, are found in the granular layer. We labeled 
the epidermal proteins with C4 C]leucine and [aH]histidine, and 
caJculated the ratio of histidine/leucine incorporation after 
various treatments (Table III). Both DFMO and MGBG de-
creased the ratio slightly, and the decline was more pronounced 
after the combined treatment (Table III). 
TopicaJ spermidine treatment resulted in a 2-fold increase in 
the ep~d~rmal spermidine content (Table I). When given alone, 
sp~rmidme appeared to have a marginal stimulatory effect on 
ep1de.rmal DNA synthesis (Table II), while protein synthesis 
remamed unchanged (Table III) . We have earlier shown that 
spermidine treatment prevents the uptake of MGBG into 
mouse epidermis [29], and the decrease of cellular MGBG is 
r~~ected by the cellula1· adenosylmethionine decarboxylase ac-
tivity, as aJso shown in Table I. The inhibition of DNA and 
protein synthesis caused by combined DFMO-MGBG treat-
ment ~o~ld be partially reversed by concomitant application of 
spermidme: the inhibition of DNA and protein synthesis was 
corr~cted by about 55% (Tables II, III). Similarly, the histidine/ 
leucme ratiO was partially "normalized" (Table III). 
DISCUSSION 
<?ell division seems to be strictly dependent on normaJ poly-
amme le~e~s, and ~nhi~itors of polyamine synthesis generally 
exert a distmct antiproliferative action on cultured cells and on 
animaJ tumors [14]. These observations have provoked an 
interest concerning the possible usefulness of polyamine anti-
metabolites in the treatment of neoplastic and hyperprolifera-
tive diseases. Some clinical triaJs have already been carried out 
using DFMO in the treatment of leukemia [26) and psoriasis 
[ 40]. MGBG, on the other hand, was used in the treatment of 
human malignancies long before its connection with polyamine 
metabolism was revealed [ 41]. Because of its narrow therapeutic 
index the drug was gradually withdrawn from clinicaJ use. 
However, promising results recently were obtained in leukemia 
when the dosing of the drug was guided by carefully monitoring 
the MGBG levels in blood and in leukemia cells [26,42]. 
The chances of avoiding the side effects of MGBG were 
greatly increased when the concept of DFMO "priming" was 
discovered [27]. Pretreatment with DFMO was found to greatly 
increase the uptake of MGBG into cells. Moreover, since both 
the decrease of polyamine levels by DFMO and the uptake of 
MGBG is most efficient in actively dividing cells [21], the 
inhibitors obviously act rather selectively on neoplastic cells 
and other hyperplastic tissues. 
Our previous studies have shown that the DFMO "priming" 
concept is potentially useful also in the treatment of epidermal 
tissue [23,29]. The present results indicate that a combined use 
of DFMO and MGBG elicits a profound inhibition of epidermal 
DNA synthesis, not achieved with either of the drugs aJone 
(Table II). 
Both DNA synthesis and cell division occur only in the basal 
layer of epidermis. Since DFMO and MGBG act most effec-
tively on proliferating cells, specific accumulation of MGBG 
into basal cells could be expected. However, while in cell culture 
the drugs are directly available in the medium, in skin they 
must first penetrate through the upper epidermaJ layers, which 
form an effective barrier especially for polar ionizable sub-
stances such as DFMO and MGBG. The high drug concentra-
tions used to circumvent this difficulty are likely to affect aJso 
the cells that form the differentiating surface layers of epider-
mis. The results in Table III suggest that the effect of MGBG 
on epidermal protein synthesis is in no way restricted to basal 
cells. The changes in the ratio of histidine/leucine incorporation 
indicate that the synthesis of histidine-rich keratin proteins in 
the granular layer is aJso inhibited by both DFMO and MGBG 
(Table III). Although the changes in the labeling may be partly ?ue to differences in the size of the cellular amino acid pools or 
m the uptake of the radioactive precursors (small differences 
could, in fact, be observed in the acid-soluble radioactive frac-
tion among the groups), the results clearly indicate that the 
topical treatment, probably owing to a rather massive accu-
mulation of the drugs near the surface of the skin, affects the 
function of all epidermal cell layers. 
The present study shows that DNA synthesis and, conse-
quently, skin proliferation can be locally inhibited by a com-
bined use of DFMO and MGBG. The combination should be 
potentially useful aJso in the treatment of human hyperproli-
fera~ive. skin diseases such as psoriasis, inasmuch as the sys-
temic side effects of MGBG can be avoided by the local appli-
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TABLE III. Effect of 2-difluoromethylomithine (DFMO), methylglyoxal bis(guanylhydrazone) (MGBG), and spermidine on epidermal protein 
synthesis as measured by {' 4C]leucine and {"H]histidine inc01poration 
Treatment(/ 
['"'C]Leucine 
incorporation 
(cpm/ mg protein) 
["H]Histidine 
incorporation 
(cpm/ mg protein) 
Histidine/ leuc ine 
ratio 
Protein content 
(pg/ mg tissue) 
None 
DFMO 
MGBG 
DFMO+MGBG 
DFMO +MGBG + 
spermidine 
600 ± 38b 
502 ± 17c 
425 ± 51c 
335 ± 64c 
492 ± 28 
702 ± 111 
541 ± 63c 
437 ± 123" 
304 ± 133" 
516 ± n c 
1.17 ± 0.03 
1.08 ± O.OT 
1.03 ± 0.09' 
0.91 ± 0.07" 
1.05 ± 0.11c 
147 ± 4 
130 ± 4'" 
141 ± 7 
118 ± 2" 
137 ± 8 
Spermidine 553 + 25 665 ± 39 1.21 ± 0.06 146 ± 8 
"The schedule of the treatments is described in Materials and Methods. 
"Mean± SEM. 
c p < 0.05. 
d p < 0.001. 
c p < 0.01. 
cation technique. Furthermore, the use of polyamine antime-
tabolites together with other drugs for psoriasis, e.g., retinoids, 
could lead to a synergistic effect of both drugs. Preliminary 
clinical studies for the development of a practical and effective 
treatment schedule for polyamine antimetabolites in psoriasis 
are presently in progress. 
We wish to thank Ms. Riitta Sinervirta for the excellent technical 
assistance, and Ms. Heini Howard for typing the manuscript. 
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Selective Aberration and Pigment Loss in Melanosomes of Malignant 
Melanoma Cells in Vitro by Glycosylation Inhibitors: Premelanosomes as 
Glycoprotein* 
YUTAKA MISHIMA, M.D. , PH.D. AND GENJI lMOKA w A, M.S. 
Department of Dermatology, Kobe University School of Medicine, Kobe, Japan 
We have found that glucosamine (1 mg/ml) or tunica-
mycin (0.2-0.4 1-lg/ml), specific inhibitors of lipid carrier-
dependent glycosylation of protein, when added to cul-
tured B-16 melanoma cells produce a marked loss of 
pigmentation, accompanied by distinctive. biochemical 
as well as ultrastructural aberrations in their melano-
genic compartments. Electron microscopic analysis 
shows that these newly induced unpigmented cells form 
uniquely altered melanosomes containing little or no 
melanin, although their population is not substantially 
reduced. Within the melanogenic compartments, selec-
tive aberration of melanosomes is seen, that is, deform-
ity, bulging, and segregation of their interior membrane, 
as well as the intramelanosomal formation of irregularly 
concentric lamellar structure. No apparent structural 
deformity of Golgi apparatus, Golgi-associated endo-
plasmic reticulum of lysosome (GERL), and coated vesi-
cles has been observed. · Further, no substantial altera-
tion is seen in mitochondria or other cellular structures. 
Quantitative analysis of altered and nonaltered mela-
nosomes has revealed that the ratio of altered premelan-
osomes to the total number increases to 44% in glucosa-
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Abbreviations: 
dopa: L-3,4-dihydroxy-phenylalanine 
GERL: Golgi-associated endoplasmic reticulum of lysosome 
GTA: glutaraldehyde 
Glc: glucosamine 
TM: tunicamycin 
mine-treated cells and to 99.5% in tunicamycin-treated 
cells, compared to 13% in the control. 
Electron microscopic dopa reaction has also revealed 
that these altered melanosomes seem to exhibit a weakly 
positive or a negative dopa reaction in both glucosamine-
and tunicamycin-treated melanoma cells although a 
number of dopa-positive altered melanosomes are still 
seen. However, GERL and coated vesicles show no ap-
parent decrease in dopa reaction. It may be concluded 
that glycoprotein synthesis is integral to the formation 
of normal melanosomes and to their specific melanizing 
function, which could be impaired by inhibition of the 
synthesis of asparagin-linked mannose-containing sugar 
chains. This results in retrogressive changes in the pre-
melanosomal tyrosinase during its maturation process. 
In 1980, we reported much higher tyrosinase activity in the 
Golgi-associated endoplasmic reticulum of lysosome (GERL) 
and coated vesicle fraction than that in the premelanosome 
fraction of the pigment cells [1]. It has been found that tyrosin-
ase synthesized by ribosomes is condensed and activated in the 
GERL-coated vesicle system, acquiring the capacity to form 
dopa-melanin in vitro. Thus, the transfer system or the acti-
vated ty:rosinases into premelanosomes by the possible fun ction 
of coated vesicles is presumed to be necessary for the initiation 
of melanogenesis in vivo. 
T yrosinase has been shown to exist in 3 forms, T 1, T ", and T a 
in the intracellular m elanogenic compartments [2-5], depending 
on its stage of maturation, which primarily involves its glyco-
sylation. Further we have recently found the carbohydrate 
moiety of T~ possesses melanogenically essential properties 
different from those of T 1, the synthesis of which is not inter-
rupted by current glycosylation inhibitors [6]. The core se-
quence of N-glycosidically linked oligosacchar ides is a key 
structm e ofT:, tyrosinase for its melanization-inducing function 
in premelanosomes [6). 
It has been shown that the carbohydrate moieties of glyco-
proteins in various cellular membranes have a role in the 
